Efectos adversos del implante subdérmico en mujeres de edad fértil del Hospital Regional Hermilio Valdizán Medrano de enero a agosto del 2023

Abstract

Objective. To determine the adverse effects of the subdermal implant in fertile-aged women at the Regional Hospital Hermilio Valdizán Medrano from January to August 2023. Methodology. An observational, analytical, cross- sectional, and retrospective study was conducted with a sample of 126 fertile- aged women attended at the hospital, where data collection was carried out through the documentary analysis of clinical records. Results. The documentary analysis revealed that 87.37% (83) of the women were between 18 and 35 years old, with a majority (57.89%, 55) having secondary education and originating from urban areas (50.53%, 48). 64.21% (61) were engaged in household chores (housewives), and 61.05% (58) were cohabiting patients. Regarding gynecological-obstetric factors, 51.58% (49) were primigravida and 46.32% (44) primiparous. Regarding implant removal, 51.58% (49) used it for less than 6 months, and 92.63% (88) did not require removal. Regarding adverse effects, 100% (95) presented menstrual disorders, with amenorrhea being the most common (53.68%, 51). Additionally, 25.26% (24) experienced headache, 6.32% (6) acne, 93.68% (89) weight gain, and 18.95% (18) breast tension. 100.00% (95) did not manifest local infection. Conclusion. The subdermal implant carries adverse effects such as menstrual disorders, headache, acne, weight gain, and breast tension.